Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

153 Press Releases
DateTitleCompany
21 Jul 16 Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) Eli Lilly ,
Published by
PharmiWeb.com
21 Jul 16 U.S. FDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults Eli Lilly ,
Published by
PharmiWeb.com
21 Jul 16 Diversity of Lilly's Alzheimer's Disease Pipeline Showcased at the Alzheimer's Association International Conference® 2016 (AAIC® 2016) Eli Lilly and Company,
Published by
PR Newswire
13 Jul 16 Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer Eli Lilly and Company,
Published by
PR Newswire
23 Jun 16 Diabetes Scholars Foundation Announces 2016 Scholarship Recipients Eli Lilly and Company,
Published by
PR Newswire
09 Jun 16 Lilly and American Migraine Foundation Announce $1 Million Grant for Launch of First Patient Registry to Advance Research and Development in Migraine Eli Lilly and Company,
Published by
PR Newswire
01 Jun 16 Lilly Announces Diabetes Commercial Update Investor Call Eli Lilly and Company,
Published by
PR Newswire
31 May 16 Lilly Announces Webcast to Discuss Abemaciclib Data Eli Lilly and Company,
Published by
PR Newswire
31 May 16 U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes Eli Lilly and Company,
Published by
PR Newswire
11 May 16 Eli Lilly’s Taltz Could Achieve Blockbuster Status in Plaque Psoriasis Market by 2022, says GlobalData Anlayst Eli Lilly,
Published by
PharmiWeb.com
10 May 16 Eli Lilly and Company marks 140 years of caring and discovery Eli Lilly and Company,
Published by
PR Newswire
02 May 16 Lilly's Taltz® (ixekizumab) Now Available in the U.S. for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
12 Apr 16 Lilly to Provide Detailed Update of Pipeline and R&D Strategy at Upcoming Investment Community Meeting Eli Lilly and Company,
Published by
PR Newswire
04 Apr 16 Lilly Confirms Date and Conference Call for First-Quarter 2016 Financial Results Announcement Eli Lilly and Company,
Published by
PR Newswire
18 Mar 16 Eli Lilly's stock drops sharply again, to lead health care sector lower Eli Lilly,
Published by
PharmiWeb.com
03 Mar 16 CHMP Recommends Approval of Lilly’s Ixekizumab [TALTZ®] for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company ,
Published by
PharmiWeb.com
26 Feb 16 Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis Eli Lilly and Company,
Published by
PR Newswire
12 Feb 16 UK Court Rules Against Lilly in Alimta Vitamin Regimen Patent Lawsuit Eli Lilly and Company,
Published by
PR Newswire
02 Nov 15 Eli Lilly and Company Announces Expansion of Indianapolis R&D Headquarters Eli Lilly and Company,
Published by
PR Newswire
05 Feb 16 American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease Management Skills, Confidence and Stress Eli Lilly ,
Published by
PharmiWeb.com
11 Feb 16 Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation Eli Lilly and Company,
Published by
PR Newswire
11 Nov 15 Detailed Results Demonstrate Baricitinib Superiority to Adalimumab in Improving Signs and Symptoms of Rheumatoid Arthritis Eli Lilly and Company,
Published by
PharmiWeb.com
11 Nov 15 Patients Show Significant Improvement in Signs and Symptoms of Psoriatic Arthritis, Less Progression of Structural Joint Dama... Eli Lilly and Company,
Published by
PharmiWeb.com
27 Jan 16 Lilly and Roche Diagnostics to Collaborate on Alzheimer's Disease Adjunct Diagnostic Tool Eli Lilly and Company,
Published by
PR Newswire
15 Dec 15 Juan R. Luciano elected to Lilly board of directors Eli Lilly and Company,
Published by
PR Newswire
15 Dec 15 Lilly Sets Dates and Conference Calls for 2016 Financial Guidance and Fourth-Quarter 2015 Financial Results Eli Lilly and Company,
Published by
PR Newswire
18 Dec 15 FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment Eli Lilly ,
Published by
PharmiWeb.com
27 Jan 16 U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin) Eli Lilly ,
Published by
PharmiWeb.com
27 Jan 16 https://investor.lilly.com/releasedetail.cfm?releaseid=951493 Eli Lilly ,
Published by
PharmiWeb.com
04 Nov 15 Lilly to Participate in Credit Suisse 2015 Healthcare Conference Eli Lilly and Company,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.